Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study [0.03%]
南亚大流行COVID-19社区传播的时空模式和趋势：以孟加拉国为例
Ariful Islam,Md Abu Sayeed,Md Kaisar Rahman et al.
Ariful Islam et al.
South Asian (SA) countries have been fighting with the pandemic novel coronavirus disease 2019 (COVID-19) since January 2020. Earlier, the country-specific descriptive study has been done. Nevertheless, as transboundary infection, the borde...
Estimation of the case fatality rate of COVID-19 epidemiological data in Nigeria using statistical regression analysis [0.03%]
统计回归分析在尼日利亚COVID-19流行病学数据中对病例致死率的估计
Ahmad Abubakar Suleiman,Aminu Suleiman,Usman Aliyu Abdullahi et al.
Ahmad Abubakar Suleiman et al.
Following the emergence of COVID-19 outbreak, numbers of studies have been conducted to curtail the global spread of the virus by identifying epidemiological changes of the disease through developing statistical models, estimation of the ba...
Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland [0.03%]
中国内地冠状病毒病2019爆发期间的流感活动情况
Mi Liu,Lizong Deng,Dayan Wang et al.
Mi Liu et al.
Since coronavirus disease 2019 (COVID-19) might circulate in the following seasons, it is essential to understand how COVID-19 influences other respiratory diseases, especially influenza. In this study, we analyzed the influenza activity fr...
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 [0.03%]
2020年北京新发地市场新冠疫情再发的基因组特征分析
Yong Zhang,Yang Pan,Xiang Zhao et al.
Yong Zhang et al.
After 56 days without coronavirus disease 2019 (COVID-19) cases, reemergent cases were reported in Beijing, China on June 11, 2020. Here, we report the genetic characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro [0.03%]
假型新冠系统的开发及其有效性（通过中和效率和体外入侵抑制测试）
Ren Yang,Baoying Huang,Ruhan A et al.
Ren Yang et al.
With the development of the COVID-19 epidemic, there is an urgent need to establish a system for determining the effectiveness and neutralizing activity of vaccine candidates in biosafety level 2 (BSL-2) facilities. Previously, researchers ...
Tackling COVID-19: Insights from the Qinghai Province plague prevention and control (PPC) model [0.03%]
抗击COVID-19：来自青海鼠疫防治模型的启示
Haisheng Wu,Qingwen Zhang,Hailian Wu et al.
Haisheng Wu et al.
Plague, caused by Yersinia pestis, is a natural focus infectious disease. In China, plague is classified as category A, with the highest risk and hazard among the infectious diseases. Qinghai used to be considered as one of the most serious...
Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2 [0.03%]
两种TaqMan实时反转录PCR测定方法的发展用于检测严重急性呼吸系统综合征冠状病毒-2
Yiwei Liu,Yingying Wang,Xinming Wang et al.
Yiwei Liu et al.
The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, was caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid detection of viral nucleic acids is critical for the...
Li Guo,Shasha Liu,Jingdong Song et al.
Li Guo et al.
Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pos...
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study [0.03%]
中国武汉由SARS-CoV-2感染引起的42例死亡的流行病学和临床特征：一项回顾性研究
Nan Zhang,Haochen Yao,Dong Zhang et al.
Nan Zhang et al.
This study described the epidemiologic and clinical characteristics of patients who died from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and pointed out the potential risk factors associated with fatal outcomes....
Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? [0.03%]
卡介苗预防COVID-19的争论：是否值得进行临床试验？
Asma Binte Aziz,Jennifer L Dembinski,Yasmin Jahan
Asma Binte Aziz
The non-specific beneficial effects of Bacille Calmette-Guérin (BCG) vaccination suggest that this vaccine might play a role in protecting individuals against severe coronavirus disease 2019 (COVID-19). Several studies propose that BCG vac...